NeucaLTS:0MJR 97 Median PS Value is zł859.16 as of Jun. 29, 2026, which is 100% below its 10-year median of 1.21. GuruFocus rates LTS:0MJR with a GF Score™ of 97/100 and a GF Value™ of zł940.71. The stock has 4 warning signs investors should review. Among 70 Medical Distribution companies, Neuca ranks worse than 60% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Neuca's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł2999.559. Neuca's 10-Year median PS Ratio is 0.2864. Therefore, the Median PS Value for today is zł859.16.
As of today (2026-06-29), Neuca's share price is zł760.00. Neuca's Median PS Value is zł859.16. Therefore, Neuca's Price to Median PS Value for today is 0.88.
The historical rank and industry rank for Neuca's Median PS Value or its related term are showing as below:
LTS:0MJR'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.83 Med: 1.21 Max: 2.05
Current: 0.88
During the past 13 years, the highest Price to Median PS Value of Neuca was 2.05. The lowest was 0.83. And the median was 1.21.
LTS:0MJR's Price-to-Median-PS-Value is ranked worse than 60% of 70
companies
in the Medical Distribution industry
Industry Median: 0.81
vs LTS:0MJR: 0.88
Neuca (LTS:0MJR) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Neuca's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
760.00
/
859.16
=
0.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuca Median PS Value Related Terms
Neuca Median PS Value Historical Data
* Premium members only.
The historical data trend for Neuca's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0MJR vs MCK, CAH, COR: Median PS Value Comparison
For the Medical Distribution subindustry, Neuca's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuca Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Neuca's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Neuca's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.2864.
Neuca's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł2999.559.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuca (LTS:0MJR) has a Median PS Value of zł859.16 as of Jun. 29, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Neuca and its competitors. This is 70905% above median its historical median of 1.21. Over the past decade, Neuca's Median PS Value has ranged from 0.83 to 2.05. According to the industry distribution chart, Neuca ranks #42 out of 70 companies in the Medical Distribution industry, placing it in the top 60%.
Is Neuca's Median PS Value too high?
Neuca's current Median PS Value of zł859.16 is 70905% above median its 10-year median of 1.21. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 2.05. Based on the distribution chart, Neuca ranks #42 out of 70 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Neuca has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's Median PS Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Neuca ranks #42 out of 70 companies for Median PS Value. This places Neuca in the lower half of its industry. The industry median Median PS Value is 0.81. Historically, Neuca's own Median PS Value has ranged from 0.83 to 2.05 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.81, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Neuca and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuca's current Median PS Value is zł859.16, which is 70905% above median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (LTS:0MJR) has a current Median PS Value of zł859.16. The stock's GF Value™ is zł940.71, compared to a current price of zł760.00 — trading 19.2% below its estimated fair value. The current Median PS Value is zł859.16, which is 70905% above median its 10-year median of 1.21. Neuca's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current Median PS Value is zł859.16 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuca (LTS:0MJR) Overvalued in 2026?
Based on GuruFocus' analysis, Neuca stock appears to be undervalued.
The current stock price of zł760.00 is trading 19.2% below its estimated GF Value™ of zł940.71.
Key valuation signals for LTS:0MJR:
Median PS Value: zł859.16 (70905% above median its 10-year median of 1.21)
GF Value™: zł940.71 vs. price of zł760.00 (19.2% below fair value)
No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
97GF Score
Get the complete analysis for LTS:0MJR
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0MJR has been successfully added to your 
